NODALITY

Nodality’s Single Cell Network Profiling (SCNP) technology provides robust, human cell-based translational models of disease, drug activity and patient responses. SCNP reveals complex biology at the single-cell level, creating competitive advantages in addressing many of the most pressing challenges in drug discovery and development for cancer and autoimmune disease. Appointed Ralph Snyderman to BOD, Feb. 2014. Website: http://www.nodality.com/

 

Web Analytics